Human-Induced Pluripotent Stem Cell Technology and Cardiomyocyte Generation: Progress and Clinical Applications
Open Access
- 24 May 2018
- Vol. 7 (6), 48
- https://doi.org/10.3390/cells7060048
Abstract
Human-induced pluripotent stem cells (hiPSCs) are reprogrammed cells that have hallmarks similar to embryonic stem cells including the capacity of self-renewal and differentiation into cardiac myocytes. The improvements in reprogramming and differentiating methods achieved in the past 10 years widened the use of hiPSCs, especially in cardiac research. hiPSC-derived cardiac myocytes (CMs) recapitulate phenotypic differences caused by genetic variations, making them attractive human disease models and useful tools for drug discovery and toxicology testing. In addition, hiPSCs can be used as sources of cells for cardiac regeneration in animal models. Here, we review the advances in the genetic and epigenetic control of cardiomyogenesis that underlies the significant improvement of the induced reprogramming of somatic cells to CMs; the methods used to improve scalability of throughput assays for functional screening and drug testing in vitro; the phenotypic characteristics of hiPSCs-derived CMs and their ability to rescue injured CMs through paracrine effects; we also cover the novel approaches in tissue engineering for hiPSC-derived cardiac tissue generation, and finally, their immunological features and the potential use in biomedical applications.Keywords
This publication has 166 references indexed in Scilit:
- Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditionsCell Research, 2013
- Production of De Novo Cardiomyocytes: Human Pluripotent Stem Cell Differentiation and Direct ReprogrammingCell Stem Cell, 2012
- Methods in cardiomyocyte isolation, culture, and gene transferJournal of Molecular and Cellular Cardiology, 2011
- Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signalsCell Research, 2010
- Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen controlJournal of Biotechnology, 2010
- MicroRNAs in cardiomyocyte developmentWires Systems Biology and Medicine, 2010
- Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndromeNature, 2010
- The microwell control of embryoid body size in order to regulate cardiac differentiation of human embryonic stem cellsBiomaterials, 2009
- Micro-bioreactor arrays for controlling cellular environments: Design principles for human embryonic stem cell applicationsMethods, 2008
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006